Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

No reported Other Non-Cash Items figures are available to summarize.

Other Non-Cash Items history

Currency unavailable · from the cash flow

No Other Non-Cash Items data reported for this period type.

Other Non-Cash Items vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Other Non-Cash Items for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$133.92M USD+1446.6%+117.4%47.5%
ANABAnaptysBio, Inc.LTM Mar 2026$78.61M USD+42.2%-12.8%33.8%
ALMSAlumis Inc. Common StockLTM Jun 2026$44.46M USD+123.1%+1204.6%601.0%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$33.58M USD-41.1%—37.1%
ORKAOruka Therapeutics, Inc.LTM Sep 2026$14.93M USD+1516.1%+227.4%—
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$4.76M USD-94.7%-21.2%56.9%
IMUXImmunic, Inc.LTM Mar 2026$595K USD+331.5%-76.4%—
ODTXOdyssey Therapeutics, Inc.—— ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ODTX) —+123.1%+52.3%47.5%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.